4.5 Review

Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

Emerging technologies and their impact on regulatory science

Elke Anklam et al.

Summary: There is a growing need for safety assessment of food, drugs, and personal care products, driven by the utilization of emerging cellular, molecular, and in silico technologies. The rapid advancement and convergence of these technologies may impact regulatory decisions and approvals, but the lack of thorough evaluation raises concerns about their readiness for regulatory application. Developing strategies to evaluate these new technologies and ensuring their appropriate and rapid incorporation into regulatory use is crucial for the regulatory science field to keep pace with advancements and prepare for emerging global challenges. Collaboration between the regulatory community and technology developers is essential to harness collective capabilities for evaluating new assessment tools effectively.

EXPERIMENTAL BIOLOGY AND MEDICINE (2022)

Article Toxicology

The Future of Uncertainty Factors With In Vitro Studies Using Human Cells

Michael Dourson et al.

Summary: New approach methodologies, particularly in vitro toxicology methods using human cells, are challenging traditional regulatory risk assessments. The use of human cells on a chip may eliminate the interspecies uncertainty factor, but additional data is needed to reduce or eliminate the intraspecies uncertainty factor. Collaboration between traditional risk assessors and those working with modern technologies is important to move forward.

TOXICOLOGICAL SCIENCES (2022)

Review Anatomy & Morphology

Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development

Passley Hargrove-Grimes et al.

Summary: This review discusses the obstacles to the widespread adoption of MPS technology and how end-users can help overcome these barriers to achieve broader adoption of the technology.

CELLS TISSUES ORGANS (2022)

Article Toxicology

A Model of Human Small Airway on a Chip for Studies of Subacute Effects of Inhalation Toxicants

Courtney Sakolish et al.

Summary: In this study, a multilayered microfluidic device was developed to mimic human small airway in vitro for studying the subacute effects of inhalation toxicants. The device was capable of generating quantitative, high-content data indicative of aberrant changes in the small airway epithelium due to inhalational exposures.

TOXICOLOGICAL SCIENCES (2022)

Editorial Material Biotechnology & Applied Microbiology

Opportunities and challenges with microphysiological systems: a pharma end-user perspective

Lorna Ewart et al.

Summary: Research has shown that utilizing human-relevant in vitro models can help reduce attrition in drug development, but the adoption of microphysiological systems models by pharmaceutical companies remains limited. Greater collaboration among stakeholders is needed to fully realize the potential of these models.

NATURE REVIEWS DRUG DISCOVERY (2021)

Review Biotechnology & Applied Microbiology

Organs-on-chips: into the next decade

Lucie A. Low et al.

Summary: OoCs, also known as microphysiological systems or 'tissue chips', have the potential to be informative at multiple stages of drug discovery and development, providing insights into normal human organ function and disease pathophysiology, as well as predicting the safety and efficacy of investigational drugs in humans. The field of OoCs has seen significant advances in recent years, but there are still challenges and opportunities that need to be addressed to fully realize their potential for translational research.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Medicine, Research & Experimental

Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation

Andres Rubiano et al.

Summary: The study characterized the reproducibility of liver microphysiological systems (MPSs) in predicting hepatic drug effects through experiments on drug toxicity, metabolism, and intracellular accumulation. The results demonstrated that the liver MPS can reliably produce consistent experimental outcomes for drug evaluation applications, showing better stability and functionality compared to other culture platforms. The study also provided general considerations and recommendations for using liver MPSs in drug development.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Article Pharmacology & Pharmacy

Analysis of reproducibility and robustness of a human microfluidic four-cell liver acinus microphysiology system (LAMPS)

Courtney Sakolish et al.

Summary: The human microfluidic liver acinus microphysiology system (LAMPS) was evaluated for drug pharmacokinetics and toxicology, showing robustness and reproducibility when seeded with primary human hepatocytes or iPSC-derived hepatocytes, and demonstrating more physiologically and clinically relevant effects compared to 2D cultures.

TOXICOLOGY (2021)

Letter Biotechnology & Applied Microbiology

Adoption of organ-on-chip platforms by the pharmaceutical industry

Paul Vulto et al.

NATURE REVIEWS DRUG DISCOVERY (2021)

Review Medicine, Research & Experimental

3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration

Hongbing Wang et al.

Summary: Nonclinical testing is crucial for evaluating potential risks and effectiveness of new drugs. Current 2D in vitro systems lack accuracy in simulating in vivo processes, while animal studies have limitations. Researchers are developing novel 3D models to improve drug safety and efficacy predictions.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Review Biochemistry & Molecular Biology

Multi-organ-on-a-chip for pharmacokinetics and toxicokinetic study of drugs

Jong Hwan Sung

Summary: This article reviews recent advances in multi-organ-on-a-chip platforms and their combination with mathematical models for predicting drug PK and TK. Despite some challenges that remain, significant progress in this field indicates tangible outcomes that can be utilized in the pharmaceutical industry in the near future.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)

Article Environmental Sciences

Update and Evaluation of a High-Throughput In Vitro Mass Balance Distribution Model: IV-MBM EQP v2.0

James M. Armitage et al.

Summary: The study evaluates an updated mass balance model for predicting the distribution of organic chemicals in in vitro test systems, finding that performance varies depending on data set, chemical properties, and model assumptions, but overall remains acceptable.

TOXICS (2021)

Review Toxicology

Applicability of organ-on-chip systems in toxicology and pharmacology

Marlon R. Schneider et al.

Summary: The application of Organ-on-chip (OoC) systems in safety and efficacy assessment presents both advantages and challenges, with issues related to throughput, standardization, and transferability. Standardized protocols are crucial for regulatory application of OoCs, while initiatives like open technology platforms and collaboration between developers and risk assessors may help build confidence in their application.

CRITICAL REVIEWS IN TOXICOLOGY (2021)

Editorial Material Multidisciplinary Sciences

Human microphysiological systems for drug development

Adrian Roth

SCIENCE (2021)

Article Pharmacology & Pharmacy

Prediction of hepatic drug clearance with a human microfluidic four-cell liver acinus microphysiology system

Courtney Sakolish et al.

Summary: The study compared the ability of a microphysiology system to predict hepatic clearance for seven representative compounds. The results suggest that using iPSC-derived hepatocytes with an empirical scaling factor may provide more accurate and precise estimates of hepatic clearance.

TOXICOLOGY (2021)

Editorial Material Cell & Tissue Engineering

Putting Science into Standards workshop on standards for organ-on-chip

Monica Piergiovanni et al.

Summary: The European Commission Joint Research Centre and the European Standardization Organizations CEN and CENELEC organized a workshop focusing on organ-on-chip technologies to identify needs and priorities for standards development and suggest possible ways forward.

STEM CELL REPORTS (2021)

Article Biochemical Research Methods

Standardisation needs for organ on chip devices

Monica Piergiovanni et al.

Summary: Organ on chip devices are at the forefront of biotechnologies, with the potential to revolutionize the life sciences. Standardization is crucial for proper characterization of devices and efficient communication among stakeholders. Around 90 standards are available for the field of organ on chip technology.

LAB ON A CHIP (2021)

Review Toxicology

Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project

Seiichi Ishida

Summary: Microphysiological systems (MPS) have been actively developed as a new technology for in vitro toxicity testing platforms, with the potential to become next-generation in vitro toxicity assessment systems. MPS involve culture techniques to reconstruct specific organ or tissue functions in a limited space, creating miniaturized human test systems.

FRONTIERS IN TOXICOLOGY (2021)

Review Engineering, Biomedical

Organ-on-a-chip: recent breakthroughs and future prospects

Qirui Wu et al.

BIOMEDICAL ENGINEERING ONLINE (2020)

Article Toxicology

A Next-Generation Risk Assessment Case Study for Coumarin in Cosmetic Products

Maria T. Baltazar et al.

TOXICOLOGICAL SCIENCES (2020)

Article Biochemistry & Molecular Biology

Interstitial flow regulates in vitro three-dimensional self-organized brain micro-vessels

Agathe Figarol et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Review Biotechnology & Applied Microbiology

Translational Roadmap for the Organs-on-a-Chip Industry toward Broad Adoption

Vanessa Allwardt et al.

BIOENGINEERING-BASEL (2020)

Article Biochemical Research Methods

Applications of the microphysiology systems database for experimental ADME-Tox and disease models

Mark Schurdak et al.

LAB ON A CHIP (2020)

Article Medicine, Legal

Reflections on the progress towards non-animal methods for acute toxicity testing of chemicals

Helen Prior et al.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)

Review Pharmacology & Pharmacy

Impact of organ-on-a-chip technology on pharmaceutical R&D costs

Nora Franzen et al.

DRUG DISCOVERY TODAY (2019)

Article Medicine, Legal

Developing OECD test guidelines for regulatory testing of nanomaterials to ensure mutual acceptance of test data

Kirsten Rasmussen et al.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)

Article Pharmacology & Pharmacy

In Vitro Research Reproducibility: Keeping Up High Standards

Cordula Hirsch et al.

FRONTIERS IN PHARMACOLOGY (2019)

Review Pharmacology & Pharmacy

Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery

Lorna Ewart et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)

Review Pharmacology & Pharmacy

Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips

Rachelle Prantil-Baun et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)

Article Medicine, Research & Experimental

3S-Systematic, Systemic, and Systems Biology and Toxicology

Lena Smirnova et al.

ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2018)

Article Medicine, Research & Experimental

Recommendation on Test Readiness Criteria for New Approach Methods in Toxicology: Exemplified for Developmental Neurotoxicity

Anna Bal-Price et al.

ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2018)

Article Multidisciplinary Sciences

Technology Transfer of the Microphysiological Systems: A Case Study of the Human Proximal Tubule Tissue Chip

Courtney Sakolish et al.

SCIENTIFIC REPORTS (2018)

Editorial Material Medicine, Research & Experimental

Organs-on-chips: Progress, challenges, and future directions

Lucie A. Low et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2017)

Editorial Material Medicine, Research & Experimental

Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective

Lorna Ewart et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2017)

Article Chemistry, Multidisciplinary

The CompTox Chemistry Dashboard: a community data resource for environmental chemistry

Antony J. Williams et al.

JOURNAL OF CHEMINFORMATICS (2017)

Article Multidisciplinary Sciences

Comment: The FAIR Guiding Principles for scientific data management and stewardship

Mark D. Wilkinson et al.

SCIENTIFIC DATA (2016)

Article Biochemistry & Molecular Biology

Facilitating the commercialization and use of organ platforms generated by the microphysiological systems (Tissue Chip) program through public-private partnerships

Christine A. Livingston et al.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2016)

Editorial Material Medicine, Research & Experimental

Organs-on-chips (microphysiological systems): tools to expedite efficacy and toxicity testing in human tissue

Kristin M. Fabre et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2014)

Editorial Material Medicine, Research & Experimental

Developing Microphysiological Systems for Use as Regulatory Tools - Challenges and Opportunities

Melvin E. Andersen et al.

ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2014)

Article Mathematical & Computational Biology

Regulatory advice and drug development-A case study in negotiating with regulators

Jorgen Seldrup

STATISTICS IN MEDICINE (2011)

Article Biotechnology & Applied Microbiology

Microscale culture of human liver cells for drug development

Salman R. Khetani et al.

NATURE BIOTECHNOLOGY (2008)

Article Biotechnology & Applied Microbiology

Microfluidics - downsizing large-scale biology

P Mitchell

NATURE BIOTECHNOLOGY (2001)